Angie Maynard, PharmD, MS, BCOP, discusses RCC immunotherapy guidelines, treatment selection, toxicity management, and pharmacists’ clinical role.
Angie Maynard, PharmD, MS, BCOP
Advertisement
Articles by Angie Maynard, PharmD, MS, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Beyond Off-Label: How Auvelity's Approval Changes Agitation Management in Alzheimer Disease
2
What Does the FDA Advisory Committee’s Vote on 7 Peptides Mean for Pharmacy Practice?
3
What the Peptide Vote Actually Changes at My Counter (Hint: Not Much, Yet)
4
GLP-1s May Curb Lung Fibrosis in Diabetes, Long COVID
5